Prestige Consumer Healthcare
PBH
#4655
Rank
A$3.32 B
Marketcap
A$70.20
Share price
-0.11%
Change (1 day)
-39.33%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): A$5.87

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.65. In 2025 the company made an earnings per share (EPS) of A$5.46 a decrease over its 2024 EPS that were of A$6.16.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.877.48%
2025A$5.46-11.4%
2024A$6.16-367.08%
2023A-$2.31-138.33%
2022A$6.0211.7%
2021A$5.3913.6%
2020A$4.75-651.67%
2019A-$0.86-148.78%
2018A$1.76-83.29%
2017A$10.55437.23%
2016A$1.96-34.13%
2015A$2.9852.94%
2014A$1.95-8.11%
2013A$2.12
2011A$1.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.52 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.02 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.06 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.88-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.17-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.86 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$3.31-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.57-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.47-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.75-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel